VANI Vivani Medical Inc
Price (delayed)
$1.01
Market cap
$59.84M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.43
Enterprise value
$58.11M
Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in
Highlights
The EPS is up by 14% year-on-year and by 2.3% since the previous quarter
The debt has decreased by 9% QoQ and by 7% YoY
The equity has contracted by 15% YoY and by 3.9% from the previous quarter
The company's quick ratio fell by 14% YoY
Key stats
What are the main financial stats of VANI
Market
Valuations
Earnings
Shares outstanding
59.24M
Market cap
$59.84M
Enterprise value
$58.11M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.4
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$24.68M
Net income
-$23.49M
EBIT
-$23.49M
EBITDA
-$22.81M
Free cash flow
-$21.34M
Per share
Balance sheet
Liquidity
EPS
-$0.43
EPS diluted
-$0.43
Free cash flow per share
-$0.39
Book value per share
$0.3
Revenue per share
$0
TBVPS
$0.76
Total assets
$41.56M
Total liabilities
$23.95M
Debt
$17.97M
Equity
$17.61M
Working capital
$14.46M
Debt to equity
1.02
Current ratio
3.41
Quick ratio
3.29
Net debt/EBITDA
0.08
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-50.4%
Return on equity
-106.2%
Return on invested capital
-66%
Return on capital employed
-66%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VANI stock price
How has the Vivani Medical stock price performed over time
Intraday
-0.98%
1 week
-9.82%
1 month
-9.01%
1 year
-46.28%
YTD
-12.93%
QTD
-3.81%
Financial performance
How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$24.68M
Net income
-$23.49M
Gross margin
N/A
Net margin
N/A
Vivani Medical's net income has increased by 8% YoY
VANI's operating income is up by 8% YoY
Growth
What is Vivani Medical's growth rate over time
Valuation
What is Vivani Medical stock price valuation
P/E
N/A
P/B
3.4
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 14% year-on-year and by 2.3% since the previous quarter
VANI's price to book (P/B) is 45% less than its 5-year quarterly average of 6.2 and 2% less than its last 4 quarters average of 3.5
The equity has contracted by 15% YoY and by 3.9% from the previous quarter
Efficiency
How efficient is Vivani Medical business performance
Vivani Medical's return on invested capital has increased by 24% YoY but it has decreased by 2.6% QoQ
The return on equity has declined by 22% year-on-year and by 3.7% since the previous quarter
The return on assets has declined by 2.4% since the previous quarter
Dividends
What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VANI.
Financial health
How did Vivani Medical financials performed over time
The total assets is 74% more than the total liabilities
Vivani Medical's current ratio has decreased by 15% YoY
The company's quick ratio fell by 14% YoY
The debt is 2% higher than the equity
The equity has contracted by 15% YoY and by 3.9% from the previous quarter
VANI's debt to equity is up by 10% year-on-year but it is down by 4.7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.